GN denies involvement in false advertising case

GN Hearing acquired US-based online platform Lively after the latter had stopped its misleading marketing, and did therefore not take part in the advertising slipup that led to a settlement in the US including payments to the state of Connecticut. Even so, the mistake won’t be repeated with GN at the helm, it says.

Photo: GN Store Nord / PR

Hearing aid manufacturer GN Hearing is washing its hands of any culpability for a recent misleading marketing blunder in the US, which resulted in settlements between four companies and the Connecticut Office of the Attorney General.

Four hearing firms had marketed some hearing aids as “FDA-approved” when they were in fact only registered with the agency. Among those reprimanded by Connecticut Attorney General William Tong were WS Audiology and digital marketing platform Lively. In December, GN Hearing acquired 91 percent of Lively shares.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Further reading

Related articles

Latest news

See all jobs